desk
Share
News Topical, Digital Desk : Dr. Reddy's Laboratories Ltd announced the resignation of its top management after the stock market closed on Monday. Jayant Sridhar, the Global Head of the Biologics division of the company, has resigned from his post. The company stated in an exchange filing that Jayant Sridhar will terminate his services with the company by the end of business hours on January 31, 2026. Jayant Sridhar said in his resignation, "I am resigning from the position of Global Head of Biologics at Dr. Reddy's Laboratories Ltd to pursue my personal and professional aspirations outside the company."
Hyderabad-based pharmaceutical company Dr. Reddy's Laboratories Limited reported a net profit of ₹1,347 crore for the September quarter, a 7.3% increase from ₹1,256 crore in the same period last year.
Stock Performance: The company's shares closed at ₹1,198.50 on Monday, down 0.57%. Over the past year, the company's stock has declined 6.94%.
Read More: Is digital gold just regular gold? Understanding this is crucial.
--Advertisement--
